Our Mission: To improve the treatment and the lives of patients with leukaemia, lymphoma and other haematological malignancies by advancing ‘leading edge’ clinical trials in Australasia, and to be regarded by the local and international community as the peak research body for these diseases within our geographical areas of operation and influence.
Cancers of the blood, bone marrow and lymph nodes, collectively called "blood cancers", are some of the most commonly diagnosed cancers. Many types of blood cancer are incurable and clinical research is critical to ensure that new and more effective treatments are made available to people with these diseases.
Clinical trials are vital to establish if new drugs and treatments are safe and effective before they can be made widely available to the community.
The ALLG is the only not-for-profit, collaborative clinical research group in Australia and New Zealand dedicated to designing and conducting independent clinical trials for the treatment of blood cancers.
The ALLG provides the infrastructure and governance necessary for Australian and New Zealand clinicians and scientists to work together to conduct multi-disciplinary clinical research into blood cancers. Currently, more than 600 clinicians, scientists and support staff across Australia and New Zealand contribute to ALLG research.
By conducting multi-site, collaborative clinical trials, ALLG researchers play a pivotal role in influencing blood cancer treatment practice worldwide and improving outcomes for people suffering from these diseases.